Dipyridyl

Dipyridyl

SCHEMBL2946110

c1ccc(-c2ccccn2)nc1.c1conn1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 10/20 0.58
▸ LMNA P02545 3/20 0.58
▸ CCR1 P32246 3/20 0.58
▸ CCR5 P51681 3/20 0.58
▸ CCR8 P51685 3/20 0.58
▸ CYP1A2 P05177 2/20 0.58
▸ POLB P06746 1/20 0.58
▸ METAP1 P53582 1/20 0.58
▸ BLM P54132 1/20 0.58
▸ HIF1A Q16665 1/20 0.58
▸ DOHH Q9BU89 1/20 0.58
▸ P4HTM Q9NXG6 1/20 0.58
▸ NPC1 O15118 7/20 0.50
▸ RAB9A P51151 6/20 0.50
▸ TP53 P04637 5/20 0.50
▸ SMN1; SMN2 Q16637 4/20 0.50
▸ ALOX15 P16050 3/20 0.50
▸ L3MBTL1 Q9Y468 3/20 0.50
▸ ALDH1A1 P00352 3/20 0.50
▸ HTT P42858 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naphthalene SCHEMBL27805984 0.78 CYP2A6 (0.40) ALDH1A1CYP2A6
SCHEMBL26099015 0.78 — —
Quinoxaline SCHEMBL27493680 0.77 ALDH1A1 (0.38) KDM4ECYP1A2POLBNPC1RAB9A
SCHEMBL27753337 0.77 ALDH1A1 (0.43) KDM4ELMNACYP1A2POLBBLM
Dipyridyl SCHEMBL8685663 0.77 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL9299834 0.77 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL7732129 0.77 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL809479 0.77 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8
SCHEMBL1181563 0.77 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL29351528 0.76 KDM4E (1.00) KDM4ELMNACCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7754348-B2 charge transfer compounds; glass transition temperature; heat resistance; low driving voltage LUMINESCENE TECHNOLOGY CORP. (TW) 2010-07-13 — — US disclosed
US-20080265746-A1 PHENANTHROLINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME Yen, Feng Wen (TW) 2008-10-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080265746-A1 PHENANTHROLINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME AHR, HAX1, ARNT KDM4E 2523/4885LMNA 1498/4885CCR1 1740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback